| R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease.
Authors: Meijers B, Poesen R, Claes K, Dietrich R, Bammens B, Sprangers B, Naesens M, Storr M, Kuypers D, Evenepoel P
Kidney Int, 2015;87(1):210-6.
Species: Human
Sample Type: Serum
Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.
Authors: Gilder A, Jones K, Hu J, Wang L, Chen C, Carter B, Gonias S
J Biol Chem, 2015;290(24):14798-809.
Species: Human
Sample Type: Serum
Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China.
Authors: Guo S, Han M, Chen M, Ning Y, Pei G, Li Y, Dai W, Ge S, Deng Y, Guo Y, Li X, Haller H, Xu G, Rong S
PLoS ONE, 2015;10(9):e0138718.
Species: Human
Sample Type: Plasma
p-Cresol affects reactive oxygen species generation, cell cycle arrest, cytotoxicity and inflammation/atherosclerosis-related modulators production in endothelial cells and mononuclear cells.
Authors: Chang M, Chang H, Chan C, Yeung S, Hsien H, Lin B, Yeh C, Tseng W, Tseng S, Jeng J
PLoS ONE, 2014;9(12):e114446.
Species: Human
Sample Type: whole cells
Serum-soluble urokinase receptor concentration in primary FSGS.
Authors: Maas RJ, Wetzels JF, Deegens JK
Kidney Int., 2012;81(10):1043-4.
Species: Human
Sample Type: Serum
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.
Authors: Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J
Nat. Med., 2011;17(8):952-60.
Species: Human
Sample Type: Serum
Identification of regulatory Hck and PAI-2 proteins in the monocyte response to PEG-containing matrices.
Authors: Zuckerman ST, Brown JF, Kao WJ
Biomaterials, 2009;30(23):3825-33.
Species: Human
Sample Type: Cell Culture Supernates
The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions.
Authors: Beaufort N, Leduc D, Eguchi H, Mengele K, Hellmann D, Masegi T, Kamimura T, Yasuoka S, Fend F, Chignard M, Pidard D
Am. J. Physiol. Lung Cell Mol. Physiol., 2007;292(5):L1263-72.
Species: Human
Sample Type: Cell Culture Supernates
Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma.
Authors: Brooks AM, Bates ME, Vrtis RF, Jarjour NN, Bertics PJ, Sedgwick JB
Am. J. Respir. Cell Mol. Biol., 2006;35(4):503-11.
Species: Human
Sample Type: BALF
Low oxygen concentrations inhibit trophoblast cell invasion from early gestation placental explants via alterations in levels of the urokinase plasminogen activator system.
Authors: Lash GE, Otun HA, Innes BA, Bulmer JN, Searle RF, Robson SC
Biol. Reprod., 2005;74(2):403-9.
Species: Human
Sample Type: Cell Culture Supernates
The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.
Authors: Wang J, Stockton DW, Ittmann M
Clin. Cancer Res., 2004;10(18):6169-78.
Species: Human
Sample Type: Cell Lysates
Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients.
Authors: Rigolin GM, Tieghi A, Ciccone M, Bragotti LZ, Cavazzini F, Della Porta M, Castagnari B, Carroccia R, Guerra G, Cuneo A, Castoldi G
Br. J. Haematol., 2003;120(6):953-9.
Species: Human
Sample Type: Serum
Pretreatment determination of the serum urokinase plasminogen activator and its soluble receptor in advanced small-cell lung cancer or non-small-cell lung cancer.
Authors: Cobos E, Jumper C, Lox C
Clin. Appl. Thromb. Hemost., 2003;9(3):241-6.
Species: Human
Sample Type: Serum
The circulating urokinase plasminogen activator (uPA) and its soluble receptor (suPAR) are not up-regulated by the circulating P105 fraction of the HER-2/neu proto-oncogene: in vivo evidence from patients with advanced non-small cell lung cancer (NSCLC).
Authors: Jumper C, Cobos E, Lox C
Anticancer Res., 2002;22(4):2073-6.
Species: Human
Sample Type: Serum
|
